Inventor

Adrian S. Ray

Inventor
Redwood City, CA, US

Overview

34→
Patents
2005–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 34 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
C07HSugars16%
C07DHeterocyclic compounds10%
Y02ATechnologies for adaptation to climate change8%
Y02PClimate change mitigation technologies in the production or processing of goods3%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,695,357Methods for treating filoviridae virus infections202010,696,679Methods and compounds for treating paramyxoviridae virus infections202010,695,361Methods for treating arenaviridae and coronaviridae virus infections202010,456,414Methods for treating HCV201910,251,904Methods for treating arenaviridae and coronaviridae virus infections201910,251,898Methods for treating Filoviridae virus infections201910,065,958Methods and compounds for treating Paramyxoviridae virus infections20189,949,994Methods for treating 20189,724,360'Methods for treating Filoviridae virus infections'20179,579,332'Phosphonate analogs of HIV inhibitor compounds'20179,549,941'Compositions and methods for treating hepatitis C virus'20179,457,035'Antiviral compounds'20169,452,154'Methods for treating HCV'20169,393,256'Methods for treating HCV'20169,139,604'Antiviral phosphonate analogs'20158,889,159'Compositions and methods for treating hepatitis C virus'20148,871,785'Antiviral phosphonate analogs'20148,697,861'Antiviral compounds'20148,455,451'2\'-fluoro substituted carba-nucleoside analogs for antiviral treatment'20138,435,969'Method and compositions for treating hematological malignancies'20138,415,308'1′-substituted-carba-nucleoside prodrugs for antiviral treatment'20138,329,926'Antiviral compounds'20128,318,701'Phosphonate analogs of HIV inhibitor compounds'20128,163,718'Nucleoside analogues containing phosphonate or phosphonamide groups'20128,022,083'Antiviral phosphonate analogs'20117,973,013'2\'-fluoro substituted carba-nucleoside analogs for antiviral treatment'20117,871,991'Phosphonate analogs of HIV inhibitor compounds'20117,645,747'Therapeutic phosphonate compounds'20107,470,724'Phosphonate compounds having immuno-modulatory activity'20087,452,901'Anti-cancer phosphonate analogs'20087,432,261'Anti-inflammatory phosphonate compounds'20087,429,565'Antiviral phosphonate analogs'20087,427,624'Purine nucleoside phosphorylase inhibitory phosphonate compounds'20086,900,315'2-amino-9H-purin-9-yl compounds and methods for inhibiting/treating HIV infections and AIDS related symptoms'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005Based in New Haven, CT, US· patent location history
2008–2020Patents assigned to GILEAD SCIENCES INC (29)· patent assignee history
2008–2011Based in San Mateo, CA, US· patent location history
2011–2020Based in Redwood City, CA, US· patent location history
2012–2013Patents assigned to RAY ADRIAN S (6)· patent assignee history
2012–2013Patents assigned to ZHANG LIJUN (3)· patent assignee history
2012Patents assigned to BOOJAMRA CONSTANTINE G (2)· patent assignee history
2014–2019Patents assigned to GILEAD PHARMASSET LLC (4)· patent assignee history
2016–2020Based in Burlingame, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD SCIENCES INC292008–2020
RAY ADRIAN Sself62012–2013
GILEAD PHARMASSET LLC42014–2019
ZHANG LIJUN32012–2013
BOOJAMRA CONSTANTINE G22012
Locations
LocationPatentsSpan
Redwood City, California, US182011–2020
San Mateo, California, US82008–2011
Burlingame, California, US72016–2020
New Haven, CT, US12005